Regulations.gov document
Reference 3 FDA Memorandum to All Registered Blood Establishments: “Revised…
Supporting & Related Material · FDA-2005-D-0140 · posted Dec 28, 2017
Key facts
| Document ID | FDA-2005-D-0140-0014 |
|---|---|
| Title | Reference 3 FDA Memorandum to All Registered Blood Establishments: “Revised Recommendations for Testing Whole Blood, Blood Components, Source Plasma and Source Leukocytes for Antibody to Hepatitis C Virus Encoded Antigen (Anti-HCV),” August 5, 1993. |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2005-D-0140 |
| Posted | Dec 28, 2017 |
At a glance
- None Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: